Anesthesia Considerations for Myasthenia Gravis

Introduction to Anesthesia Management

The American Society of Anesthesiologists recommends a 50-75% dose reduction of non-depolarizing muscle relaxants, such as atracurium, cisatracurium, and rocuronium, in patients with myasthenia gravis due to their heightened sensitivity, and succinylcholine should be avoided due to paradoxical resistance requiring higher doses 1, 2

The European Society of Anaesthesiology recommends using rocuronium, atracurium, or cisatracurium at 50-75% of standard doses due to increased sensitivity and prolonged duration of action in MG patients 1, 2
The dose reduction correlates directly with disease severity—more severe MG requires greater reductions, as stated by the American College of Physicians 1
Benzylisoquinoline agents, such as atracurium and cisatracurium, are preferred in patients with concurrent renal or hepatic impairment due to organ-independent elimination, according to the National Institute of Diabetes and Digestive and Kidney Diseases 1, 3

The American Society of Anesthesiologists mandates quantitative neuromuscular monitoring with train-of-four (TOF) ratio measurement when any muscle relaxant is used in MG patients, with a strength of evidence level I 1, 2, 3
Baseline TOF ratio should be measured before administering muscle relaxants—if TOF <0.9 at baseline, sensitivity to non-depolarizing agents is significantly greater and doses must be further reduced, as recommended by the European Society of Anaesthesiology 1

The American College of Cardiology recommends sugammadex as the preferred reversal agent for rocuronium-induced neuromuscular blockade in MG patients, not neostigmine, due to its rapid and predictable reversal 1, 2, 3

The American Academy of Neurology recommends continuing pyridostigmine on the day of surgery, including the morning dose, to maintain baseline muscle strength and reduce the risk of respiratory distress 5
Aminoglycosides and fluoroquinolones should be avoided as they worsen neuromuscular transmission, according to the Infectious Diseases Society of America 5

The American Society of Anesthesiologists recommends propofol for induction due to its short duration allowing rapid respiratory assessment, though it may cause hypotension 5
Sevoflurane or isoflurane are safe inhalational agents for maintenance, as stated by the National Institute of Environmental Health Sciences 6

The American Thoracic Society recommends ensuring TOF ratio >0.9 before extubation to confirm complete reversal of neuromuscular blockade, with a strength of evidence level II 1
Standard recovery room care is appropriate if trigger-free anesthesia was provided, according to the British Journal of Anaesthesia 7

The American Society of Regional Anesthesia and Pain Medicine recommends regional anesthesia, such as spinal, epidural, or peripheral nerve blocks, or local anesthesia as an excellent choice for MG patients when surgically appropriate, completely avoiding the risks associated with muscle relaxants and general anesthesia 7